Target & Activity
| Target | Activity | Value |
|---|---|---|
| NF-κB |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 786-0 | IC50 | 26.8 μM | Cytotoxicity against VHL-deficient human 786-0 cells assessed as reduction in cell viability incubated for 4 days by XTT assay | [PMID: 31260889] |
| 786-0 | IC50 | 43.8 μM | Cytotoxicity against VHL-positive human 786-0 cells assessed as reduction in cell viability incubated for 4 days by XTT assay | [PMID: 31260889] |
| A2780 | EC50 | 3.5 μM | Cytotoxicity against human A2780 cells measured after 96 hrs by SRB assay | [PMID: 31158743] |
| A549 | IC50 | 26.8 μM | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | [PMID: 20673727] |
| A549 | EC50 | 27.9 μM | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | [PMID: 12027739] |
| A549 | IC50 | 80 μM | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay | [PMID: 33210536] |
| A549 | IC50 | 83.6 μM | Cytotoxicity against human A549 cells by MTT assay | [PMID: 18952420] |
| A549 | IC50 | 9.72 μM | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | [PMID: 26638042] |
| B16-BL6 | EC50 | 6.79 μM | Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay | [PMID: 12027739] |
| B16-F10 | IC50 | 10.68 μM | Antiproliferative activity against mouse B16F10 cells after 72 hrs by MTT assay | [PMID: 26638042] |
| Bel-7402 | IC50 | 5.5 μM | Cytotoxicity against human Bel7402 cells by MTT assay | [PMID: 18952420] |
| BEL-7404 tumor cell line | IC50 | 14.5 μM | Cytotoxicity against human Bel7404 cells after 72 hrs by MTT assay | [PMID: 20673727] |
| BeWo | IC50 | 2.96 μM | Antitumor activity against human Bewo cells assessed as inhibition of cell growth by MTT assay | [PMID: 25160837] |
| BGC-823 | IC50 | 19.3 μM | Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay | [PMID: 20673727] |
| BV-2 | IC50 | 6.4 μM | Inhibition of nitric oxide production in LPS-stimulated mouse BV2 cells treated 3 hrs before LPS addition measured after 24 hrs by Griess assay | [PMID: 23870700] |
| BV-2 | IC50 | 6.4 μM | Antineuroinflammatory activity in mouse BV2 cells assessed as reduction of LPS-induced nitric oxide production treated 3 hrs before LPS addition measured after 24 hrs by Griess assay | [PMID: 23726032] |
| BV-2 | IC50 | 6.4 μM | Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production preincubated for 3 hrs followed by LPS challenge measured after 24 hrs by Griess assay | [PMID: 24697335] |
| Caco-2 | IC50 | 11.35 μM | Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay | [PMID: 26638042] |
| CNE | IC50 | 54 μM | Cytotoxicity against human CNE cells after 72 hrs by MTT assay | [PMID: 20673727] |
| DU-145 | IC50 | 16 μM | Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay | [PMID: 27979593] |
20 records · Scroll to view more